Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2021 > Vol 2, №8 (2021) > Risk management of micro- and macrovascular complications of diabetes mellitus: the importance of glycemic self-control

Risk management of micro- and macrovascular complications of diabetes mellitus: the importance of glycemic self-control

Olga A. Polyakova , Dinara G. Gusenbekova , Olga D. Ostroumova

For citation:


  • Abstract
  • About the Author
  • References

Abstract

As the incidence of obesity, unhealthy lifestyles and an aging population increases, the global prevalence of diabetes mellitus (DM) is projected to rise sharply in the coming decades. A significant part of the burden of DM is associated with the development of micro- and macrovascular complications, which are the cause of a deterioration in the quality of life, disability and premature death of patients with DM. Cardiovascular disease (CVD) is the leading cause of death in patients with DM, especially those with type 2 DM The risk of CVD in people with DM is 2–4 times higher than in people without DM, and this risk increases with the deterioration of glycemic control. Disorders of the glycemic profile such as hyperglycemia, hypoglycemia and high variability of glycemia negatively affect the prognosis of patients with DM. Self-monitoring of blood glucose is an effective tool for managing DM, which allows not only achieving the target level of glycated hemoglobin and minimizing glycemic variability, but predicting the risk of severe hypoglycemia.

Key words: diabetes mellitus, micro- and macrovascular complications, hypoglycemia, hyperglycemia, glycemic variability, glycemic self-control.

About the Author

Olga A. Polyakova 1 , Dinara G. Gusenbekova 1 , Olga D. Ostroumova 1

1 Russian Medical Academy of Continuous Professional Education, Moscow, Russia

References

1. International Diabetes Federation. IDF diabetes atlas. 10th edition. 2021. Accessed November 10, 2021. https://diabetesatlas.org/
2. Healthcare in Russia. 2019: Statistical collection/Rosstat. Moscow, 2019. Accessed November 1, 2021. https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2019.pdf (in Russian).
3. Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes mellitus. 2019; 22 (2S): 4–61. DOI: 10.14341/DM12208 (in Russian).
4. Van Dieren S, Beulens JW, van der Schouw YT et al. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010; 17 (Suppl. 1): S3-S8. DOI: 10.1097/01.hjr. 0000368191.86614.5a
5. Kengne AP, Patel A, Marre M et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 2011; 18 (3): 393–8. DOI: 10.1177/1741826710394270
6. De Rosa S, Arcidiacono B, Chiefari E et al. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. Front Endocrinol (Lausanne) 2018; 9: 2. DOI: 10.3389/fendo.2018.00002
7. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation 2016; 133 (24): 2459–502. DOI: 10.1161/circulationaha.116.022194
8. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006; 368 (9529): 29–36. DOI: 10.1016/S0140-6736(06)68967-8
9. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17 (1): 83. DOI: 10.1186/s12933-018-0728-6
10. Ballotari P, Ranieri SC, Luberto F et al. Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy). Int J Endocrinol 2015; 2015: 914057. DOI:10.1155/2015/ 914057
11. Dal Canto E, Ceriello A, Rydén L et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 2019; 26 (Suppl. 2): 25–32. DOI: 10.1177/2047487319878371
12. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI:10.1155/2017/7839101
13. Emerging Risk Factors Collaboration, Sarwar N, Gao P et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375 (9733): 2215–22. DOI: 10.1016/S0140-6736(10)60484-9
14. Anand SS, Dagenais GR, Mohan V et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Prev Cardiol 2012; 19 (4): 755–64. DOI: 10.1177/1741826711409327
15. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 2013; 34 (31): 2436-43. DOI: 10.1093/eurheartj/ eht149
16. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI:10.1155/2017/7839101
17. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010; 106 (8): 1319–31. DOI: 10.1161/CIRCRESAHA.110.217117
18. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation 2016; 133 (24): 2459–502. DOI: 10.1161/circulationaha.116.022194
19. Zhang Y, Hu G, Yuan Z, Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One 2012; 7 (8): e42551. DOI: 10.1371/journal.pone.0042551
20. Cavender MA, Scirica BM, Raz I et al. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. Am J Med 2016; 129 (3): 340.e1-340.e3408. DOI: 10.1016/j.amjmed.2015.09.022
21. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321 (7258): 405–12. DOI:10.1136/bmj.321.7258.405
22. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33 (6):1389–94. DOI: 10.2337/dc09-2082
23. Laitinen T, Lyyra-Laitinen T, Huopio H et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol 2008; 13 (2): 97–105. DOI:10.1111/j. 1542-474X.2008.00208.x
24. Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the 'dead in bed' syndrome revisited. Diabetologia 2009; 52 (1): 42–5. DOI: 10.1007/s00125-008-1177-7
25. Robinson RT, Harris ND, Ireland RH et al. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 2003; 52 (6): 1469–74. DOI: 10.2337/diabetes.52.6.1469
26. Perros P, Deary IJ, Sellar RJ et al. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 1997; 20 (6): 1013–8. DOI: 10.2337/diacare.20.6.1013
27. Whitmer RA, Karter AJ, Yaffe K et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301 (15): 1565–72. DOI: 10.1001/jama.2009.460
28. de Galan BE, Zoungas S, Chalmers J et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009; 52 (11): 2328–36. DOI: 10.1007/ s00125-009-1484-7
29. Yun JS, Park YM, Han K et al. Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study. Cardiovasc Diabetol 2019; 18 (1): 103. DOI: 10.1186/s12933-019-0909-y
30. Paulus WJ, Dal Canto E. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. JACC Heart Fail 2018; 6 (1): 1–7. DOI: 10.1016/j.jchf.2017.07.012
31. Umpierrez GE, P Kovatchev B. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes. Am J Med Sci 2018; 356 (6): 518–27. DOI: 10.1016/j.amjms.2018.09.010
32. Scott ES, Januszewski AS, O'Connell R et al. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. J Clin Endocrinol Metab 2020; 105 (10): dgaa361. DOI: 10.1210/clinem/dgaa361
33. Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol 2019; 7 (3): 221–30. DOI: 10.1016/S2213-8587(18)30136-0
34. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI: 10.1155/2017/7839101
35. Nauck MA, Haastert B, Trautner C et al. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Diabetologia 2014; 57 (5): 868–77. DOI: 10.1007/s00125-014-3168-1
36. Clar C, Barnard K, Cummins E et al.; Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 1–140. DOI: 10.3310/hta14120
37. Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Diabetes mellitus type 2 in adults. Diabetes mellitus. 2020; 23 (2S): 4–102. DOI: 10.14341/ DM12507 (in Russian).
38. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42 (Suppl. 1): S13–S28. DOI: 10.2337/dc19-S002
39. Cosentino F, Grant PJ, Aboyans V et al. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way. Russian Journal of Cardiology. 2020; 25 (4): 3839. DOI: 10.15829/1560-4071-2020-3839 (in Russian).
40. Bailey TS, Wallace JF, Pardo S et al. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol 2017; 11 (4): 736–43. DOI:10.1177/1932296816680829


For citation:Polyakova O.A., Gusenbekova D.M., Ostroumova O.D. Risk management of micro- and macrovascular complications of diabetes mellitus: the importance of glycemic self-control. Clinical review for general practice. 2021; 8: 36–41. DOI: 10.47407/kr2021.2.8.00098


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru